Supernus Pharmaceuticals, Inc.

MERCER GLOBAL ADVISORS INC /ADV SUPN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/18/2026

Shares

8,242

Value ($000)

410

Weight

0.0%

2021 Q2 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/18/2026	410	0.0%	8,242	12/31/2025
2025 Q3	11/14/2025	442	0.0%	9,248	9/30/2025
2025 Q2	8/14/2025	368	0.0%	11,674	6/30/2025
2025 Q1	5/15/2025	331	0.0%	10,114	3/31/2025
2024 Q4	2/14/2025	368	0.0%	10,179	12/31/2024
2024 Q3	11/14/2024	355	0.0%	11,100	9/30/2024
2024 Q2	8/12/2024	305	0.0%	11,393	6/30/2024
2024 Q1	5/15/2024	413	0.0%	12,113	3/31/2024
2023 Q4	2/15/2024	327	0.0%	11,302	12/31/2023
2023 Q3	11/15/2023	313	0.0%	11,348	9/30/2023
2023 Q2	8/14/2023	345	0.0%	11,484	6/30/2023
2023 Q1	5/16/2023	377	0.0%	10,416	3/31/2023
2022 Q4	2/9/2023	362	0.0%	10,153	12/31/2022
2022 Q3	11/15/2022	431	0.0%	12,724	9/30/2022
2022 Q2	8/10/2022	353	0.0%	12,214	6/30/2022
2022 Q1	5/10/2022	394	0.0%	12,182	3/31/2022
2021 Q4	2/4/2022	287	0.0%	9,840	12/31/2021
2021 Q3	11/10/2021	254	0.0%	9,525	9/30/2021
2021 Q2	8/10/2021	303	0.0%	9,837	6/30/2021